Beacon Pointe Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Buy |
19,985
+100
| +0.5% | +$6.55K | 0.01% | 584 |
|
|
2025
Q1 | $1.4M | Sell |
19,885
-600
| -3% | -$42.3K | 0.02% | 548 |
|
|
2024
Q4 | $1.35M | Buy |
20,485
+409
| +2% | +$26.9K | 0.01% | 564 |
|
|
2024
Q3 | $1.42M | Buy |
20,076
+410
| +2% | +$29K | 0.02% | 544 |
|
|
2024
Q2 | $1.3M | Buy |
19,666
+1,180
| +6% | +$78.3K | 0.02% | 571 |
|
|
2024
Q1 | $1.26M | Hold |
18,486
| – | – | 0.01% | 620 |
|
|
2023
Q4 | $1.14M | Sell |
18,486
-1,953
| -10% | -$121K | 0.01% | 619 |
|
|
2023
Q3 | $1.21M | Buy |
20,439
+1,395
| +7% | +$82.3K | 0.02% | 572 |
|
|
2023
Q2 | $1.14M | Sell |
19,044
-210
| -1% | -$12.5K | 0.02% | 496 |
|
|
2023
Q1 | $1.12M | Sell |
19,254
-150
| -0.8% | -$8.76K | 0.02% | 517 |
|
|
2022
Q4 | $1.2M | Buy |
19,404
+600
| +3% | +$37.2K | 0.02% | 468 |
|
|
2022
Q3 | $1.06M | Sell |
18,804
-150
| -0.8% | -$8.48K | 0.02% | 451 |
|
|
2022
Q2 | $1.22M | Sell |
18,954
-96
| -0.5% | -$6.15K | 0.03% | 422 |
|
|
2022
Q1 | $1.23M | Buy |
19,050
+270
| +1% | +$17.5K | 0.02% | 562 |
|
|
2021
Q4 | $1.25M | Sell |
18,780
-357
| -2% | -$23.8K | 0.03% | 334 |
|
|
2021
Q3 | $1.17M | Buy |
19,137
+3,126
| +20% | +$191K | 0.03% | 384 |
|
|
2021
Q2 | $991K | Buy |
+16,011
| New | +$991K | 0.04% | 339 |
|